Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-01-07 @ 7:27 AM
Study NCT ID:
NCT01415960
Status:
COMPLETED
Last Update Posted:
2017-03-03
First Post:
2011-08-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate Cancer
Sponsor:
GP-Pharm
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Prostate Cancer | View |
| None | androgen deprivation therapy. | View |
| None | Leuprolide Acetate Depot Formulation | View |
| None | Pharmacokinetics | View |
| None | testosterone | View |
| None | serum luteinizing hormone | View |
| None | follicle-stimulating hormone | View |
| None | prostate-specific antigen | View |